Vílchez JA, Roldán V, Manzano-Fernández S, Fernández H, Avilés-Plaza F, Martínez-Hernández P, Vicente V, Valdés M, Marín F, Lip GY. ?-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest. 2013 Nov;144(5):1564-70. doi: 10.1378/chest.13-0922. PubMed PMID: 23975142. FI: 5.25 PMID: 23975142

Saura D, Peñafiel P, García-Alberola A, Valdés M. Temperature affects the kinetic properties of sodium channel: fever itself unmasks the typical electrocardiographic pattern of the Brugada syndrome. Int J Cardiol. 2010 May 14;141(1):107-8. doi: 10.1016/j.ijcard.2008.11.060. Epub 2008 Dec 6. PubMed PMID: 19059658. FI: 6.802 PMID: 19059658

Marín F, Lip GY. Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not? Eur J Heart Fail. 2013 Jan;15(1):3-4. doi: 10.1093/eurjhf/hfs198. PubMed PMID: 23204212. FI: PMID: 23204212

Hernández-Romero D, Marín F, Roldán V, Lip GY. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients. J Intern Med. 2012 Oct;272(4):409. doi: 10.1111/j.1365-2796.2012.02565.x. Epub 2012 Jul 27. PubMed PMID: 22702474. FI: 5.483 PMID: 22702474

Banerjee A, Marín F, Lip GY. A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices. Stroke. 2011 Nov;42(11):3316-22. doi: 10.1161/STROKEAHA.111.617886. Epub 2011 Oct 13. Review. PubMed PMID: 21998051. FI: 5.729 PMID: 21998051

Ruiz-Nodar JM, Marín F, Manzano-Fernández S, Valencia-Martín J, Hurtado JA, Roldán V, Pineda J, Pinar E, Sogorb F, Valdés M, Lip GY. An evaluation of the CHADS? stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest. 2011 Jun;139(6):1402-9. doi: 10.1378/chest.10-1408. Epub 2010 Sep 23. PubMed PMID: 20864616. FI: 5.25 PMID: 20864616

Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18. PubMed PMID: 18641090. FI: 5.154 PMID: 18641090

Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane D, Levi M, Marín F, Palareti G, Kirchhof P; European Heart Rhythm Association. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost. 2011 Dec;106(6):997-1011. doi: 10.1160/TH11-10-0690. Epub 2011 Nov 2. PubMed PMID: 22048796. FI: 5.044 PMID: 22048796

Andreu JM, Roldán V, García-Navarro M, Ruipérez JA, Valdés M, Marín F. [Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence]. Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14. Spanish. PubMed PMID: 23021363. FI: PMID: 23021363

López-Cuenca A, Marín F, Roldán V, González-Conejero R, Hernández-Romero D, Valdés M, Lip GY. Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk. Ann Med. 2010 Dec;42(8):562-75. doi: 10.3109/07853890.2010.507601. Epub 2010 Aug 4. Review. PubMed PMID: 20681943. FI: 4.323 PMID: 20681943